Progression-free and overall survival for patients treated with frontline CFAR versus historic FCR. Kaplan-Meier analyses showing progression-free survival (A) and overall survival (B) from start of treatment for patients treated with frontline CFAR (solid line) versus an historic group of patients treated with frontline FCR (dashed line).